Piper Brian 4
4 · Aevi Genomic Medicine, Inc. · Filed Aug 15, 2017
Insider Transaction Report
Form 4
Piper Brian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase)
2017-08-11+380,000→ 380,000 totalExercise: $1.32Exp: 2027-08-11→ Common Stock (380,000 underlying)
Footnotes (1)
- [F1]The option award vests and becomes exercisable as follows (rounded up to the nearest whole share of common stock): one-third on August 11, 2018, then in 24 equal monthly installments on the 11th day of each subsequent calendar month, subject to the reporting person's continued service with the issuer.